Product Images Oxcarbazepine

This is a description for a medication called Oxcarbazepine which is in the form of oral suspension. Each 5mL of the medicine contains 300mg of NDC 65162-649-78 bazepine. The medication comes in a container that should be stored at 20-25°C and should be kept away from children. The medication guide is provided separately and should be read before use. The brand name is Doty Amneal Pharmaceuticals LLC.*

This is a label of a 300 mg/5mL Oxcarbazepine oral suspension. The label mentions the drug components and the appropriate dosage information. It also provides instructions on storage and usage. A pharmacist should disperse the medication, and the medication guide is provided separately. The product should be used within seven weeks of the opening of the bottle.*

This appears to be a statistical analysis report using log-rank test to compare the effect of Oxcarbazeping treatment versus Placebo in reducing the incidence of seizures. The data shows a p-value of 0.045, which is considered statistically significant. The table suggests that the observations were recorded over a period of 140 days, and the graph displays the progress of the treatment groups over time.*

The text describes the results of a statistical test called the "log-rank test". The test resulted in a p-value of 0.0001. Additionally, there is a graph displaying "Time to exit" in days with markers at every 10 days up to 130 days. There are two treatment groups labeled "HIGH" and "LOW". A portion of the text after the graph appears to be corrupted, so it is not clear what it describes.*